(Press-News.org) High school students learn that Pavlov’s dogs were conditioned to associate the sound of a bell with getting food. The association was so strong that the dogs would begin to salivate when they heard the bell, before there was even a whiff of food. When they were finally presented with the food, they ate it.
They did not lick the bell.
But that’s just what some animals will do when presented with a stimulus, or cue, that has been paired with a reward: interact with the cue. Sometimes they’ll paw at it and even gnaw at it, said Sara Morrison, research assistant professor in the Department of Neuroscience at Pitt’s Kenneth P. Dietrich School of Arts and Sciences. Only once the reward has been delivered will they turn their attention to that tasty sugar pellet.
Animals who display this behavior are known as sign trackers. Alternatively, goal trackers head toward the area where they expect their reward to be delivered. A study from Morrison’s lab, published in the Journal of Neuroscience on June 25, found that sign tracking is an altogether different learning process than goal tracking.
The research showed that in rats, sign trackers, learning to value a cue relies on the availability of the neurotransmitter dopamine in a particular brain region at the time they receive their reward. Neither inhibiting nor increasing dopamine had any effect on goal trackers, Morrison said, a finding contrary to the way researchers have historically thought of cue-reward associations: as dopamine-dependent. While that seems to be the case for sign trackers, Morrison’s research indicates goal tracking is reliant on a different, non-dopamine-dependent learning mechanism.
A better understanding of the neurological basis of sign tracking, and how to unlearn it, may help researchers better understand risk factors for related psychiatric disorders.
Sign tracking has been linked to risk-taking, impulsivity and substance abuse relapse. And it’s “sticky” — even after a reward is taken away, sign trackers are more likely to react to a cue than goal trackers. Even if the reward is switched to something the animals aren’t interested in, sign trackers continue to react to the cue.
The research team, led by first author Ethan Herring (A&S ’23), used rats engineered with dopamine neurons that could be turned on and off using light, a method known as optogenetics, in the brain’s ventral tegmental area. The team could inhibit or increase the release of dopamine at will.
After giving rats the 8-second cue that they had been conditioned to associate with sugar pellets, the researchers turned off dopamine neurons at the time the reward was delivered. “Inhibiting dopamine prevented the rats from learning to sign track,” Morrison said. “When we stopped the inhibition, after a few days some went on to become sign trackers again.”
Adding additional dopamine when rats received the reward, however, did not help sign trackers learn the association any faster. And when the additional stimulation was taken away, the rats stopped developing sign-tracking abilities for a few days.
“This says something really cool,” Morris said. “The signal seemed to scale to the amount of dopamine provided. It was like we were giving a bigger reward, then took half of that away.” The rats reacted as if the higher dopamine output was their baseline for a few days, after which they again began to improve as sign trackers.
That response makes sense, according to Morrison. “We all learn equally well from all different kinds of rewards. There must be some way our brain scales the rewards to the appropriate learning rate.”
END
Pavlov’s dogs were conditioned to go to their treat. Why do some animals learn to interact with the bell instead?
2025-07-15
ELSE PRESS RELEASES FROM THIS DATE:
Call for Young Editorial Board members at Current Molecular Pharmacology
2025-07-15
Current Molecular Pharmacology (CMP) is at the cutting edge of publishing the latest advancements in cellular and molecular pharmacology. We focus on the mechanisms of action of new drugs under development, innovative pharmacological technologies, and the application of genomics, proteomics, and metabonomics to drug action. The journal also delves into how studying drug actions at the cellular and molecular levels provides insights into normal biological functions, thus deepening our understanding of therapeutic interventions and fundamental biological processes.
With an impact factor of 2.9 in 2025, CMP is extensively indexed in databases such as ...
MSU team develops scalable climate solutions for agricultural carbon markets
2025-07-15
Why this matters:
Builds trust in carbon markets. This science-based baseline system dramatically improves accuracy, helping ensure carbon credits are credible and truly reflect climate benefits.
Enables real climate impact by accounting for both soil carbon and nitrous oxide emissions, the approach delivers a full, net climate assessment.
Scales across millions of acres. Tested on 46 million hectares in 12 Midwest states, this approach is ready for large-scale adoption, helping farmers transition to regenerative practices with confidence and clarity.
EAST LANSING, Mich. – New research ...
Playing an instrument may protect against cognitive aging
2025-07-15
Long-term musical training may mitigate the age-related decline in speech perception by enhancing cognitive reserve, according to a study published July 15th in the open-access journal PLOS Biology by Claude Alain from the Baycrest Academy for Research and Education, Canada, and Yi Du from the Chinese Academy of Sciences.
Normal aging is typically associated with declines in sensory and cognitive functions. These age-related changes in perception and cognition are often accompanied by increased ...
UNM study finds link between Grand Canyon landslide and Meteor Crater impact
2025-07-15
Geology is full of detective stories about Earth’s history, and a new paper in Geology by University of New Mexico Distinguished Professors Emeritus Karl Karlstrom and Laurie Crossey, along with their co-authors, links two iconic geologic landmarks of the American Southwest: the Grand Canyon and Meteor Crater.
The article, titled Grand Canyon landslide-dam and paleolake triggered by the Meteor Crater impact at 56 ka, highlights the striking coincidence in the geologic ages of a meteor impact and a landslide dam that blocked the Colorado River, forming a paleolake in the Grand Canyon about ...
Ultra-hot Jupiter’s death spiral could reveal stellar secrets
2025-07-15
Astronomers track doomed planet's death spiral
Macquarie University astronomers have tracked an extreme planet's orbital decay, confirming it is spiralling towards its star in a cosmic death dance that could end in three possible ways.
The ultra-hot Jupiter exoplanet TOI-2109b, located 870 light-years from Earth, completes an orbit around its star in just 16 hours – making it the closest hot Jupiter ever discovered.
With a mass nearly five times that of Jupiter and almost twice Jupiter's size, ...
You only get one brain! The best helmet material for protecting your noggin
2025-07-15
WASHINGTON, July 15, 2025 – Though participation in sports can have positive impacts both physiologically and socially, extreme sports, like football and roller derby, come with elevated risks. In a 2019 study, over 40% of 498 athletes suffered at least one injury over the course of the year.
These injury rates are even higher in elite cricket — around 70%, with about 13% of all injuries being to the head, neck, and face — pointing to a need for improvements in protective helmets.
In AIP Advances, by AIP Publishing, researchers ...
Neurodegeneration and stroke after GLP-1RAs in diabetes and obesity
2025-07-15
About The Study: In this cohort study, the use of glucagon-like peptide 1 receptor agonists (GLP-1RAs) semaglutide and tirzepatide was associated with a lower risk of dementia, stroke, and all-cause mortality in adults with type 2 diabetes and obesity. These findings suggest potential neuroprotective and cerebrovascular benefits of GLP-1RAs beyond glycemic control, warranting further trials to confirm these outcomes.
Corresponding author: To contact the corresponding author, James Cheng-Chung Wei, M.D., Ph.D., email jccwei@gmail.com.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi: ...
Pediatric COVID-19 hospitalization trends by race and ethnicity, 2020-2023
2025-07-15
About The Study: This study found that among pediatric patients hospitalized with COVID-19, Black and Hispanic children were disproportionately more likely to be hospitalized for COVID-19 and experience severe disease compared with white and Asian or Pacific Islander children. A higher proportion of hospitalized Black children had underlying medical conditions. This study underlines the need for targeted interventions, particularly for children with underlying medical conditions, and the need for equitable access and use of vaccines and therapeutics for disproportionately affected populations.
Corresponding author: To contact the corresponding author, ...
Research spotlight: New genetic roadmap offers insights into obesity and diabetes
2025-07-15
Q: How would you summarize your study for a lay audience?
Our study examines how RNA in extracellular vesicles (EVs) can provide insights into metabolic phenotypes related to obesity. By using functional genomics approaches, we found a high representation of genes and regulatory elements previously associated with obesity and type 2 diabetes represented by the RNA cargo within these EVs. Notably, these EV transcripts represent regulatory elements and transcriptionally active genes in adipose tissue and are associated with metabolic ...
Fred Hutch leads new Vanguard Study for Cancer Screening Research Network
2025-07-15
SEATTLE – July 15, 2025 – Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests. Researchers will evaluate whether these blood tests will help people ages 45 to 75 find cancer early when it may be easier to treat.
This is the first study of the Cancer Screening Research Network (CSRN), a nationwide network that will run trials aimed at improving cancer screening that is funded by the National Cancer Institute (NCI), part of the National Institutes of Health. Fred Hutch serves as the Coordinating and Communications ...